• News in Review

    Wellness Efforts: What Residents Really Think

    Download PDF

    Burnout. Depression. Suicide. More than two-thirds (68.4%) of U.S. oph­thalmology residents responding to a national survey reported that peers in their programs have faced these issues within the past year.1 More than a fourth (26.3%) acknowledged being in­volved in a patient case in which these problems adversely affected a medical judgment or outcome.

    The findings paint a troubling pic­ture of the burdens placed on ophthal­mic residents. And it is one that is at odds with the perceptions of residency program directors. In another survey by the same research team, only 25% of program directors expressed concern about resident wellness.2

    A surprise. While depression and burnout have been associated with resident training, the extent of stress among residents reported in this survey was surprising, said coauthor Paul B. Greenberg, MD, MPH, at Brown Uni­versity in Providence, Rhode Island.

    Findings. The survey, the first to assess the status of resident wellness in U.S. ophthalmic education from a resident’s point of view, contained 12 multiple-choice questions and provided room for comment. It was emailed to all (N = 1,048) ophthalmology residents in the United States, yielding a 23.0% response rate (n = 241). Results included the following:

    • Just one-fourth (26.7%) of respon­dents reported that their department had a formal resident wellness program.
    • Of residents in schools with wellness programs, 45.6% said their departments did not promote a culture of wellness.
    • Some 38% of residents did not know if they had access to free counsel­ing services. (In yet another disparity between ophthalmic program director and resident perceptions, 98% of program directors had reported the availability of free counseling services in their programs.)
    • Among residents who were aware of counseling services, 26.3% did not know how to access them.

    When asked what most hindered their participation in wellness programs, 25% cited a lack of time, while 16% cited the duration or scheduling of their shifts. Other barriers to partic­ipation included academic stressors, paperwork and administrative require ments, and understaffing at clinical sites.

    Rx for wellness. Dr. Greenberg noted that he hopes the study will encourage residents and graduate medical edu­cation leaders to better appreciate the value of wellness programs.

    For starters, he proposed 2 solutions: “Educate residents regarding the acces­sibility of wellness programs, and give residents time to attend them.”

    —Miriam Karmel


    1 Tran EM et al. JAMA Ophthalmol. 2018;136(6):695-701.

    2 Tran EM et al. J Surg Educ. 2018;75(1):95-103.


    Relevant financial disclosures—Dr. Greenberg: None.

    For full disclosures and the disclosure key, see below.

    Full Financial Disclosures

    Dr. Connon Atelerix: O.

    Dr. Demirci Castle Biosciences: C.

    Dr. Fant Alcon: C; BSI: C; Clinical Research Consultants: E,O; CorNeat Vision: C; EyeYon Medical: C; HumanOptics: C; Oasis Medical: C; OptoQuest: C; PromiSight: E,O; Rashmivu: C; Reichert/Ametek: C; University of Louisville Coulter Foundation: C; University of Michigan Coulter Foundation: C; VEO Ophthalmics: E,O.

    Dr. Greenberg None.

    Dr. Snyder Alcon: S; Bausch + Lomb: S; Glaukos: S; Haag-Streit: C; HumanOptics: C,P; VEO Ophthalmics: O; W.L. Gore: C.

    Disclosure Category



    Consultant/Advisor C Consultant fee, paid advisory boards, or fees for attending a meeting.
    Employee E Employed by a commercial company.
    Speakers bureau L Lecture fees or honoraria, travel fees or reimbursements when speaking at the invitation of a commercial company.
    Equity owner O Equity ownership/stock options in publicly or privately traded firms, excluding mutual funds.
    Patents/Royalty P Patents and/or royalties for intellectual property.
    Grant support S Grant support or other financial support to the investigator from all sources, including research support from government agencies (e.g., NIH), foundations, device manufacturers, and/or pharmaceutical companies.


    More from this month’s News in Review